Alliance for Regenerative Medicine’s 3rd Annual EU Advanced Therapies Investor Day
Date: 12 Nov 2015
Venue: Royal Institute of British Architects, 66 Portland Place, London W1B 1AD
Edison Investment Research invites you to the Alliance for Regenerative Medicine’s 3rd Annual EU Advanced Therapies Investor Day on 12 November in London. The event, which is supported by Edison, is free to attend for accredited investors - please RSVP to Laura Parsons at the Alliance for Regenerative Medicine. The event includes panel discussions featuring key opinion leaders on cell therapy commercialisation, targeted immunotherapies for oncology and gene therapy commercialisation.
Additional featured speakers include Martin Andrews, SVP of rare diseases at GSK and Diego Ardigo, project leader for advanced therapies at Chiesi Farmaceutici. The meeting also includes presentations from the sector’s top companies such as: Argos Therapeutics, Avita Medical, Cell Therapy, Kiadis Pharma, MaxCyte, Pluristem, ReNeuron, TiGenix, TxCell and uniQure.
Access Edison's Events Online
Please join us for the Edison Charity Bike Ride 2017
Edison, the investment research and advisory company, is once again partnering with the UK’s largest event for private investors. Now in its 15th year, the annual Master Investor Show connects investors with the CEOs and founders of exhibiting companies.
Richard Windsor, Edison's technology analyst is hosting a live webinar at 9am (GMT) on Tuesday 14th March. The webinar will be recorded for Edison TV with material relevant for those with an interest in Artificial Intelligence and the wider market implicat